Filing Details

Accession Number:
0000912282-23-000549
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-07 21:39:53
Reporting Period:
2023-12-04
Accepted Time:
2023-12-07 21:39:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1776738 Cannabist Co Holdings Inc. CBSTF Agricultural Production-Crops (100) 981488978
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1907623 Nicholas Vita C/O The Cannabist Company Holdings Inc.
680 Fifth Avenue, 24Th Floor
New York NY 10019
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2023-12-04 150,000 $0.35 20,777,075 No 4 S Indirect Held by Vita Holdings LLC
Common Shares Disposition 2023-12-05 200,000 $0.35 20,577,075 No 4 S Indirect Held by Vita Holdings LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Held by Vita Holdings LLC
No 4 S Indirect Held by Vita Holdings LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 618,950 Direct
Footnotes
  1. The sales price reported above was converted from the Canadian weighted average price of $0.478333 using an exchange rate of C$1.3541 = US$1.00. These shares were sold in multiple transactions at prices ranging from C$0.47 to $0.485, inclusive. The Reporting Person undertakes to provide to The Cannabist Company Holdings Inc., any security holder of The Cannabist Company Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The sale price reported above was converted from the Canadian weighted average price of C$0.48125 using an exchange rate of C$1.3579 = US$1.00. These shares were sold in multiple transactions at price ranging from C$0.48 to $0.485, inclusive. The Reporting Person undertakes to provide to The Cannabist Company Holdings Inc., any security holder of The Cannabist Company Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  3. Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, education and philanthropic purposes.